Cathepsin B and Cathepsin D Expression in Follicular Adenomas and Carcinomas of the Thyroid Gland

Endocrine Pathology

Volumn 8, Issue 1, 1997, Pages 49-57

  Ruhoy, Steven M ^a   Clarke, Martha R ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cathepsin B; Cathepsin D; Follicular adenoma; Follicular carcinoma; Thyroid

Indexed keywords

EID: 0141852582     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739707     Document Type: Article

References (39)

1. Farid NR, Shi Y, Zou M. Molecular basis of thyroid cancer. Endocr Rev 15:202-232, 1994.
2. Rosai J, Carcangiu ML, DeLellis R. Atlas of tumor pathology. Tumors of the thyroid gland. Washington, DC: Armed Forces Institute of Pathology, 1992; 19-63.
3. Liotta LA. Introductory overview. Cancer Metast Rev 9:285-287, 1990.
4. Norton JA, Levin B, Jensen RT. Cancer of the endocrine system. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practices of oncology. 4th ed. Philadelphia, PA: Lippincott, 1993; 1333-1350.
5. Schneider AB, Siperstein AK, Clark OH, Mazzaferri EL. Carcinoma of the follicular epithelium. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The thyroid. A fundamental and clinical text. Philadelphia, PA: Lippincott-Raven, 1991; 1121-1165.
6. Reid WA, Valler MJ, Kay J. Immunolocalization of cathepsin D in normal and neoplastic human tissues. J Clin Pathol 39:1323-1330, 1986.
7. Dunn AD. Stimulation of thyroidal thiol endopeptidases by thyrotropin. Endocrinology 114:375-382, 1984.
8. Nazeer T, Malfetano JH, Rosano TG, Ross JS. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Am J Clin Pathol 97:764-769, 1992.
9. Sinadinovic J, Cvejic D, Savin S, Micic JV, Jancic-Zguricas M. Enhanced acid protease activity of lysosomes from papillary thyroid carcinoma. Cancer 63:1179-1182, 1989.
10. Metaye T, Millet C, Kraimps J-L, Aubouin B, Barbier J, Begon F. Estrogen receptors and cathepsin D in human thyroid tissue. Cancer 72:1991-1996, 1993.
11. Ross JS, Nazeer T, Figge HL, Fisher HA, Rifkin MD. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status. Am J Clin Pathol 104:36-41, 1995.
12. Veith FO, Capony F, Garcia M, Chantelard J, Pujol H, Veith F, Zajdela A, Rochefort H. Release of estrogen induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture. Cancer Res 43:1861-1868, 1983.
13. Garcia M, Salazar-Retana G, Pages A, Richer G, Domergue J, et al. Distribution of the Mr 52,000 estrogen regulated protein in benign breast disease and other tissues by immunohistochemistry. Cancer Res 46:3734-3738, 1986.
14. Spyratos F, Brouillet JP, Defrenne A, Hacene K, Rouesse J, Maudelonde T, Brunet M, Andrieu C, Desplaces A, Rochefort H. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 2:1115-1121, 1989.
15. Henry JA, et al. Prognostic significance of the estrogen regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer 65:265-271, 1990.
16. Ravdin PM. Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res Treat 24:219-226, 1993.
17. Rochefort H, Capony F, Garcia M. Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metast Rev 9:321-331, 1990.
18. Howie AJ, Burnett D, Crocker J. The distribution of cathepsin B in human tissues. J Pathol 145:307-314, 1985.
19. Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. Mod Pathol 7:76-81, 1994.
20. Inoue T, Ishida T, Sugio K, Sugimachi K. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res 54:6133-6136, 1994.
21. Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA, Nicolson GL, Rao JS. Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metast 13:49-56, 1995.
22. Sinha M, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate 26:171-178, 1995.
23. Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, Fonseca L, Miyazaki I. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Br J Cancer 69:152-156, 1994.
24. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmert-Buck MR. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 145:301-309, 1994.
25. Lang W, Choritz H, Hundeshage H. Risk factors in follicular thyroid carcinoma: a perspective follow-up study covering a 14 year period with emphasis on morphologic findings. Am J Surg Pathol 10:246-255, 1986.
26. Hsu SM, Raine L, Fanger H. Use of avidinbiotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981.
27. Leto G, Gebbia N, Rausa L, Tumminello FM. Cathepsin D in the malignant progression of neoplastic diseases. Anticancer Res 12:235-240, 1992.
28. Dunn AD, Crutchfield HE, Dunn JT. Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes. Endocrinology 128:3073-3080, 1991.
29. Maudelonde T, Martinez P, Brouillet JP, Laffargue F, Pages A, Rochefort H. Cathepsin D in human endometrium: induction by progesterone and potential valve as a tumor marker. J Clin Endocrinol Metab 70:115-121, 1990.
30. Sloane BF. Cathepsin B and cystatins: evidence for a role in cancer progression. Sem Cancer Biol 1:137-152, 1990.
31. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 282:273-278, 1992.
32. Honn KV, Cavanaugh P, Evens C, Taylor JD, Sloane BF. Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin. Science 217:540-542, 1982.
33. Sloane BF, Moin K, Krepela E, Rozhin J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metast Rev 9:333-352, 1990.
34. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV. Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 83:2483-2487, 1986.
35. Keppler D, Abrahamson M, Sordat B. Proteases and cancer. Secretion of cathepsin B and tumour invasion. Biochem Society Transactions 22:43-48, 1994.
36. Hishimura Y, Kawabata T, Kato K. Identification of latent procathepsin B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch Biochem Biophys 261:64-71, 1988.
37. Barrett AJ. Human cathepsin B1. Purification and some properties of the enzyme. Biochem J 131:809-822, 1973.
38. Makar R, Mason A, Kittelson JM, Bowden GT, Cress AK, Nagle RB. Immunohistochemical analysis of cathepsin D in prostate carcinoma. Mod Pathol 7:747-751, 1994.
39. Visscher DW, Sarkar F, LoRusso P, Sakr W, Ottosen S, Wykes S, Crissman JD. Immunohistologic evaluation of invasion-associated proteases in breast carcinoma. Mod Pathol 6:302-306, 1993.